JPWO2020251954A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020251954A5
JPWO2020251954A5 JP2021573242A JP2021573242A JPWO2020251954A5 JP WO2020251954 A5 JPWO2020251954 A5 JP WO2020251954A5 JP 2021573242 A JP2021573242 A JP 2021573242A JP 2021573242 A JP2021573242 A JP 2021573242A JP WO2020251954 A5 JPWO2020251954 A5 JP WO2020251954A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
capsid protein
protein corresponding
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573242A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536338A5 (https=
JP2022536338A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/036846 external-priority patent/WO2020251954A1/en
Publication of JP2022536338A publication Critical patent/JP2022536338A/ja
Publication of JPWO2020251954A5 publication Critical patent/JPWO2020251954A5/ja
Publication of JP2022536338A5 publication Critical patent/JP2022536338A5/ja
Pending legal-status Critical Current

Links

JP2021573242A 2019-06-10 2020-06-09 Arsa遺伝子移入のためのアデノ随伴ウイルス組成物およびその使用方法 Pending JP2022536338A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201962859539P 2019-06-10 2019-06-10
US62/859,539 2019-06-10
US201962866374P 2019-06-25 2019-06-25
US62/866,374 2019-06-25
US201962915523P 2019-10-15 2019-10-15
US62/915,523 2019-10-15
US202062960487P 2020-01-13 2020-01-13
US62/960,487 2020-01-13
US202062987858P 2020-03-10 2020-03-10
US62/987,858 2020-03-10
US202063010970P 2020-04-16 2020-04-16
US63/010,970 2020-04-16
PCT/US2020/036846 WO2020251954A1 (en) 2019-06-10 2020-06-09 Adeno-associated virus compositions for arsa gene transfer and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2022536338A JP2022536338A (ja) 2022-08-15
JPWO2020251954A5 true JPWO2020251954A5 (https=) 2023-06-05
JP2022536338A5 JP2022536338A5 (https=) 2023-06-05

Family

ID=73782242

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573242A Pending JP2022536338A (ja) 2019-06-10 2020-06-09 Arsa遺伝子移入のためのアデノ随伴ウイルス組成物およびその使用方法

Country Status (15)

Country Link
US (1) US20220204991A1 (https=)
EP (1) EP3980447A4 (https=)
JP (1) JP2022536338A (https=)
KR (1) KR20220035107A (https=)
CN (1) CN114502575A (https=)
AU (1) AU2020292256B2 (https=)
BR (1) BR112021024855A2 (https=)
CA (1) CA3142932A1 (https=)
CL (1) CL2021003295A1 (https=)
CO (1) CO2021016797A2 (https=)
IL (1) IL288863A (https=)
MX (1) MX2021015076A (https=)
PE (1) PE20220233A1 (https=)
TW (1) TW202112807A (https=)
WO (1) WO2020251954A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769577C1 (ru) * 2021-06-01 2022-04-04 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Препарат для лечения метахроматической лейкодистрофии и способ ее лечения
AU2023273809A1 (en) * 2022-05-16 2025-01-02 Genzyme Corporation Methods of treating metachromatic leukodystrophy
JP2025525792A (ja) 2022-07-29 2025-08-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッド トランスフェリン受容体1に対して再標的化されるウイルス粒子
WO2024036250A2 (en) * 2022-08-10 2024-02-15 Homology Medicines, Inc. Adeno-associated virus compositions for arsa gene transfer and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9839696B2 (en) * 2010-04-30 2017-12-12 City Of Hope Recombinant adeno-associated vectors for targeted treatment
EP2634253B1 (en) * 2010-10-27 2016-05-11 Jichi Medical University Adeno-associated virus virions for transferring genes into neural cells
IL248102B (en) * 2014-05-02 2022-07-01 Genzyme Corp aav vectors for gene therapy of the central nervous system and retina
EP3245221A4 (en) * 2015-01-16 2018-06-13 Voyager Therapeutics, Inc. Central nervous system targeting polynucleotides
JP6836999B2 (ja) * 2015-03-24 2021-03-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California アデノ随伴ウイルス変異体及びその使用方法
HK1256341A1 (zh) * 2015-05-15 2019-09-20 明尼苏达大学董事会 用於治疗性递送到中枢神经系统的腺相关物
TWI813532B (zh) * 2015-06-18 2023-09-01 美商博得學院股份有限公司 降低脱靶效應的crispr酶突變
KR102528641B1 (ko) * 2018-02-01 2023-05-03 호몰로지 메디슨, 인크. Pah 유전자 전달을 위한 아데노-연관 바이러스 조성물 및 이의 사용 방법
US20220127625A1 (en) * 2019-02-15 2022-04-28 Generation Bio Co. Modulation of rep protein activity in closed-ended dna (cedna) production
BR112021021908A2 (pt) * 2019-05-03 2022-02-01 Univ Pennsylvania Composições úteis no tratamento da leucodistrofia metacromática

Similar Documents

Publication Publication Date Title
CA3182970A1 (en) Redirection of tropism of aav capsids
JP2020510428A5 (https=)
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
CN111819281A (zh) 用于神经变性疾病的基因疗法
JP2022501060A5 (https=)
HUE031182T2 (en) Gene therapy for spinal muscle atrophy
Blits et al. Direct gene therapy for repair of the spinal cord
WO2023061499A1 (en) Recombinant adeno-associated viral vectors for treating spinal muscular atrophy
IL300294A (en) Gene therapy using nucleic acid constructs containing methyl CPG-binding protein 2 (MECP2) promoter sequences
TW202033768A (zh) 腺相關病毒對cln6聚核苷酸的遞送
JPWO2020251954A5 (https=)
JPWO2020227166A5 (https=)
CA3238030A1 (en) Materials and methods for slc6a1 gene therapy
JPWO2020069339A5 (https=)
JPWO2022036220A5 (https=)
JPWO2021226267A5 (https=)
CN118064436B (zh) 一种增强基因表达的嵌合启动子
JPWO2020232297A5 (https=)
CN117106825B (zh) 用于治疗帕金森病的基因治疗载体及其用途
JPWO2021202817A5 (https=)
RU2021139251A (ru) Композиции аденоассоциированного вируса для переноса гена arsa и способы их применения
JPWO2020219766A5 (https=)
JPWO2022040432A5 (https=)
JPWO2022034130A5 (https=)
RU2828544C1 (ru) Препарат для стимулирования регенерации и нейропротекции нервной ткани и способ его использования